GATA3 and breast cancer: Furthermore, a sequencing study by Cohen et al. (2014) demonstrated frequent somatic mutations in GATA-3 in patients with luminal breast cancer, and that mutations occurred mostly within the DNA-binding domain of GATA-3 and were capable of modulating its activity (20).